Cargando…

Cabozantinib for the treatment of solid tumors: a systematic review

BACKGROUND: Cabozantinib is approved, in various settings, for the treatment of renal cell carcinoma, medullary thyroid cancer, and hepatocellular carcinoma, and it has been investigated for the treatment of other cancers. With the available evidence and the real-world performance of cabozantinib co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maroto, Pablo, Porta, Camillo, Capdevila, Jaume, Apolo, Andrea B., Viteri, Santiago, Rodriguez-Antona, Cristina, Martin, Lidia, Castellano, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284205/ https://www.ncbi.nlm.nih.gov/pubmed/35847482 http://dx.doi.org/10.1177/17588359221107112

Ejemplares similares

Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
por: Castellano, Daniel, et al.
Publicado: (2022)

Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
por: Grande, Enrique, et al.
Publicado: (2019)

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer
por: Capdevila, Jaume, et al.
Publicado: (2022)

Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review
por: Yang, Kaili, et al.
Publicado: (2020)

Modulation of cabozantinib efficacy by the prostate tumor microenvironment
por: Tripathi, Manisha, et al.
Publicado: (2017)

Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
por: Spini, Andrea, et al.
Publicado: (2022)

The Evolving Landscape of Leptomeningeal Cancer from Solid Tumors: A Systematic Review of Clinical Trials
por: Marenco-Hillembrand, Lina, et al.
Publicado: (2023)

Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning
por: Durán, Ignacio, et al.
Publicado: (2022)

Cabozantinib in neuroendocrine tumors: tackling drug activity and resistance mechanisms
por: Cella, Chiara Alessandra, et al.
Publicado: (2023)

Gut Microbiota and Its Repercussion in Parkinson’s Disease: A Systematic Review in Occidental Patients
por: Proano, Ana Cristina, et al.
Publicado: (2023)

Utility of Three-Dimensional Printing for Preoperative Assessment of Children with Extra-Cranial Solid Tumors: A Systematic Review
por: Anand, Sachit, et al.
Publicado: (2022)

Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial
por: Brose, Marcia S., et al.
Publicado: (2022)

Identification and economic burden of main adverse events of nerve injuries caused by regional anesthesia: a systematic review
por: Calciolari, Stefano, et al.
Publicado: (2021)

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
por: Apolo, Andrea B., et al.
Publicado: (2020)

Development of cabozantinib for the treatment of prostate cancer
por: Vaishampayan, Ulka N
Publicado: (2014)

Cabozantinib‐induced renal thrombotic microangiopathy
por: La Manna, Gaetano, et al.
Publicado: (2017)

Cabozantinib and apixaban: an hitherto unreported interaction
por: Santini, Daniele, et al.
Publicado: (2019)

Cardiovascular impact of COVID-19 with a focus on children: A systematic review
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2020)

Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)

Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma
por: Geynisman, Daniel M., et al.
Publicado: (2022)

Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis
por: Spadaccini, Marco, et al.
Publicado: (2022)

Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors
por: Ma, Yongchen, et al.
Publicado: (2019)

Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma
por: Mukaihara, Kenta, et al.
Publicado: (2017)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
por: Scirocchi, Fabio, et al.
Publicado: (2021)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
por: Jiang, Lianghai, et al.
Publicado: (2021)

Potential Molecular Targets of Oleanolic Acid in Insulin Resistance and Underlying Oxidative Stress: A Systematic Review
por: Fernández-Aparicio, Ángel, et al.
Publicado: (2022)

The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis
por: Debacker, Jens M., et al.
Publicado: (2021)

Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review
por: Giordano-Kelhoffer, Barbara, et al.
Publicado: (2022)

The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2021)

Infantile fibrosarcoma–like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib
por: Gupta, Ajay, et al.
Publicado: (2020)

Significance of Serum-Plasma Leptin Profile during Pregnancy in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Roca-Rodríguez, María del Mar, et al.
Publicado: (2022)

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
por: Pal, Sumanta K., et al.
Publicado: (2021)

Pain assessment and management in the newborn: A systematized review
por: Garcia-Rodriguez, Maria Teresa, et al.
Publicado: (2021)

(18)F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab
por: Lim, Ilhan, et al.
Publicado: (2019)

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
por: Gatti, Milo, et al.
Publicado: (2022)

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
por: Chen, Xinpei, et al.
Publicado: (2023)

The treatment landscape in thyroid cancer: a focus on cabozantinib
por: Weitzman, Steven P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_68j2ba85lca8ka9ik6vgn0ojlf